Last Updated on December 21, 2024 by The Health Master
USFDA
Dr Reddy’s Laboratories Ltd has received a clean bill of health from the stringent eyes of the United States Food and Drug Administration (USFDA).
The pharmaceutical giant announced today that its formulations manufacturing facilities, FTO-7 and FTO-9, located in Duvvada, Visakhapatnam, have successfully passed a rigorous inspection.
The USFDA has officially classified the inspection as Voluntary Action Indicated (VAI), a significant development that implies no immediate regulatory action is warranted.
This positive outcome is a testament to Dr Reddy’s commitment to adhering to the highest quality and safety standards in its manufacturing processes.
A Relief for Investors and Patients Alike
The news comes as a relief for both Dr Reddy’s investors and patients who rely on the company’s products.
The VAI classification indicates that the observed discrepancies, if any, were minor and can be rectified without disrupting the company’s operations or affecting the supply of essential medications.
This development marks the closure of an inspection that commenced on May 8, 2024, and concluded on May 17, 2024.
The company had previously disclosed the inspection on May 17, 2024.
Focus on Quality and Compliance
Dr Reddy’s has consistently demonstrated its dedication to maintaining compliance with global regulatory standards.
The successful outcome of the USFDA inspection reinforces the company’s position as a trusted and reliable pharmaceutical manufacturer.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
USFDA warns of Quality Issues with Chinese Plastic Syringe
Data integrity is the biggest issue in Pharma Industry: USFDA official
USFDA issues OAI Classification to Aurobindo Pharma Bhiwadi Facility
USFDA issues Form 483 with 3 observations to Gland Pharma
USFDA issues Form 483 with 2 observations to Gland Pharma
CDSCO Panel nod granted to study Fexuprazan HCL Tablet
Indian Pharma gets Fast Track export to Argentina
USFDA approval granted for Valbenazine Capsules
Govt boosts Pharma Companies with Revamped Scheme
Tramadol Smuggling Ring Busted: 5 arrested in Gujarat
USFDA approval granted for first Nasal Spray for allergic reactions
Drug recall: Baxter recalls Heparin Sodium Injection Due to this reason
USFDA approval granted for Trazodone tablets
CDSCO mandates WHO TRS Guidelines for Sterile Product Manufacturing
India allows Clinical Trial waivers for Drugs from these 6 Countries
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
